• Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100700, P.R.China;
SHANG Hongcai, Email: shanghongcai@126.com
Export PDF Favorites Scan Get Citation

The master protocol platform trial is a trial in which multiple treatments or different combinations of treatments are consistently evaluated in the context of a single disease, possibly within several sub-studies for different disease subtypes, allowing multiple treatments to enter or exit the trial platform based on a certain decision algorithm. Compared with the traditional clinical trial design, the master protocol platform trial as a scientific innovative model of clinical trial can accelerate drug evaluation to deal with the contradiction between the awaited evaluation of numerous drugs and lack of effective therapy for diseases. By using the large-scale randomized controlled clinical trial for COVID-19 inpatients (RECOVERY) led by the University of Oxford in the UK in 2020 as an illustration, this paper introduced the concept, design principle, and basic trial process of the master protocol platform trial to provide methodological references for clinical research of drugs.

Citation: GUAN Zhiyue, LIU Yan, ZHANG Jingjing, CHEN Ying, DAI Hengheng, ZHANG Xuecheng, HU Mingzhi, SHANG Hongcai. Design of the master protocol platform trial and its application in related fields. Chinese Journal of Evidence-Based Medicine, 2021, 21(8): 986-992. doi: 10.7507/1672-2531.202104005 Copy

  • Previous Article

    Experience and enlightenment from the design of the "All of Us" research program in the US precision medicine program